 Risks agranulocytosis aplastic anemia relation use cardiovascular drugs International Agranulocytosis Aplastic Anemia Study risks agranulocytosis aplastic anemia relation use cardiovascular drugs population-based case-control study Israel Europe total population Cardiovascular drug use week onset illness patients agranulocytosis control subjects Propranolol relative risk dipyridamole digoxin acetyldigoxin agranulocytosis excess risks attributable drugs cases persons week risks cinepazide cases control aprindine crude relative risk estimates excess risks latter drugs persons week use cardiovascular drugs period month hospital admission patients aplastic anemia control subjects Furosemide drug relative risk excess risk attributable exposure interval